Which has grown faster, ADUS or MRVI?

Over the past five years, ADUS grew revenue faster — ADUS at a 12.67% CAGR versus MRVI at -17.68%.

Is ADUS or MRVI more profitable?

ADUS runs the higher net margin — ADUS at 7.13% versus MRVI at -37.07%.

How have ADUS and MRVI total returns compared?

Over the past 5 years, ADUS delivered 8.33% and MRVI delivered -27.63% annualized total return. Past performance doesn't predict future results.

Addus HomeCare Corporation (ADUS) vs Maravai LifeSciences Holdings, Inc. (MRVI)

A side-by-side comparison of Addus HomeCare Corporation and Maravai LifeSciences Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADUS

Addus HomeCare Corporation

$2.11B

$113.21HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT

MRVI

Maravai LifeSciences Holdings, Inc.

$2.28B

$8.27HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT

Total return — ADUS vs MRVI

growth of $100 · dividends reinvested · last 6y

ADUS +18.4% (+2.9%/yr)MRVI -71.5% (-18.9%/yr)ADUS compounded faster over this window

ADUS MRVI

ADUS vs MRVI: by the numbers

•MRVI is the larger company ($2.28B vs $2.11B market cap).
•ADUS is profitable (7.13% net margin) while MRVI runs a net loss (-37.07%).
•ADUS grew revenue faster over the past five years (12.67% vs -17.68% CAGR).

Metrics side by side

Valuation

Metric	ADUS	MRVI
P/E ratio	19.86	N/A
Forward P/E	16.07	N/A
PEG ratio	0.99	N/A
P/S ratio	1.43	10.94
P/B ratio	1.84	11.16
EV / EBITDA	12.87	15.78
FCF yield	7.24%	N/A

Profitability

Metric	ADUS	MRVI
Gross margin	32.36%	17.98%
Operating margin	10.04%	-3.63%
Net margin	7.13%	-37.07%
ROE	9.17%	-37.82%
ROIC	8.61%	16.96%

Growth (annualized)

Metric	ADUS	MRVI
Revenue CAGR (5Y)	12.67%	-17.68%
EPS CAGR (5Y)	19.61%	N/A
FCF CAGR (5Y)	24.41%	N/A
Total return CAGR (5Y)	8.33%	-27.63%

Frequently asked

Which has grown faster, ADUS or MRVI?: Over the past five years, ADUS grew revenue faster — ADUS at a 12.67% CAGR versus MRVI at -17.68%.
Is ADUS or MRVI more profitable?: ADUS runs the higher net margin — ADUS at 7.13% versus MRVI at -37.07%.
How have ADUS and MRVI total returns compared?: Over the past 5 years, ADUS delivered 8.33% and MRVI delivered -27.63% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADUS analysis Full MRVI analysis Interactive comparison tool

Dig into the metrics

Addus HomeCare P/E ratio Addus HomeCare ROE Maravai LifeSciences ROE Addus HomeCare operating margin Maravai LifeSciences operating margin Addus HomeCare revenue growth Maravai LifeSciences revenue growth Addus HomeCare free cash flow Maravai LifeSciences free cash flow

Addus HomeCare & Maravai LifeSciences appear in these rankings

Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.